TY - JOUR AU - Barlesi, F. PY - 2008 DA - 2008// TI - Moving forward with tailored strategies JO - Lancet Oncol VL - 9 UR - https://doi.org/10.1016/S1470-2045(08)70290-0 DO - 10.1016/S1470-2045(08)70290-0 ID - Barlesi2008 ER - TY - JOUR AU - Azzoli, C. G. AU - Baker, S. AU - Temin, S. PY - 2009 DA - 2009// TI - American Society of Clinical Oncology clinical practice guideline update on chemotherapy for stage IV non–small-cell lung cancer JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2009.23.5622 DO - 10.1200/JCO.2009.23.5622 ID - Azzoli2009 ER - TY - JOUR AU - Hanahan, D. AU - Bergers, G. AU - Bergsland, E. PY - 2000 DA - 2000// TI - Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice JO - J Clin Invest VL - 105 UR - https://doi.org/10.1172/JCI9872 DO - 10.1172/JCI9872 ID - Hanahan2000 ER - TY - JOUR AU - André, N. AU - Carré, M. AU - Pasquier, E. PY - 2014 DA - 2014// TI - Metronomics: towards personalized chemotherapy? JO - Nat Rev Clin Oncol VL - 11 UR - https://doi.org/10.1038/nrclinonc.2014.89 DO - 10.1038/nrclinonc.2014.89 ID - André2014 ER - TY - JOUR AU - Kerbel, R. S. AU - Kamen, B. A. PY - 2004 DA - 2004// TI - The anti-angiogenic basis of metronomic chemotherapy JO - Nat Rev Cancer VL - 4 UR - https://doi.org/10.1038/nrc1369 DO - 10.1038/nrc1369 ID - Kerbel2004 ER - TY - JOUR AU - André, N. AU - Banavali, S. AU - Snihur, Y. AU - Pasquier, E. PY - 2013 DA - 2013// TI - Has the time come for metronomics in low-income and middle-income countries? JO - Lancet Oncol VL - 14 UR - https://doi.org/10.1016/S1470-2045(13)70056-1 DO - 10.1016/S1470-2045(13)70056-1 ID - André2013 ER - TY - JOUR AU - Caffo, O. AU - Dipasquale, M. AU - Murgia, V. AU - Veccia, A. AU - Galligioni, E. PY - 2013 DA - 2013// TI - An evaluation of the pharmacokinetics and clinical use of vinorelbine for NSCLC treatment JO - Expert Opin Drug Metab Toxicol VL - 9 UR - https://doi.org/10.1517/17425255.2013.804065 DO - 10.1517/17425255.2013.804065 ID - Caffo2013 ER - TY - JOUR AU - Lush, R. M. AU - McCune, J. S. AU - Tetteh, L. PY - 2005 DA - 2005// TI - The absolute bioavailability of oral vinorelbine in patients with solid tumors JO - Cancer Chemother Pharmacol VL - 56 UR - https://doi.org/10.1007/s00280-005-1025-0 DO - 10.1007/s00280-005-1025-0 ID - Lush2005 ER - TY - JOUR AU - Marty, M. AU - Fumoleau, P. AU - Adenis, A. PY - 2001 DA - 2001// TI - Oral vinorelbine pharmacokinetics and absolute bioavailability study in patients with solid tumors JO - Ann Oncol VL - 12 UR - https://doi.org/10.1023/A:1013180903805 DO - 10.1023/A:1013180903805 ID - Marty2001 ER - TY - JOUR AU - Steele, J. P. AU - Shamash, J. AU - Evans, M. T. AU - Gower, N. H. AU - Tischkowitz, M. D. AU - Rudd, R. M. PY - 2000 DA - 2000// TI - Phase II study of vinorelbine in patients with malignant pleural mesothelioma JO - J Clin Oncol VL - 18 UR - https://doi.org/10.1200/JCO.2000.18.23.3912 DO - 10.1200/JCO.2000.18.23.3912 ID - Steele2000 ER - TY - JOUR AU - Schwartz, E. L. PY - 2009 DA - 2009// TI - Antivascular actions ofmicrotubule-binding drugs JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-08-2710 DO - 10.1158/1078-0432.CCR-08-2710 ID - Schwartz2009 ER - TY - JOUR AU - Hill, S. A. AU - Lonergan, S. J. AU - Denekamp, J. AU - Chaplin, D. J. PY - 1993 DA - 1993// TI - Vinca alkaloids: anti-vascular effects in a murine tumour JO - EurJCancer VL - 29A ID - Hill1993 ER - TY - JOUR AU - Depierre, A. AU - Chastang, C. AU - Quoix, E. PY - 1994 DA - 1994// TI - Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: a randomized trial JO - Ann Oncol VL - 5 UR - https://doi.org/10.1093/oxfordjournals.annonc.a058687 DO - 10.1093/oxfordjournals.annonc.a058687 ID - Depierre1994 ER - TY - JOUR AU - Chevalier, T. AU - Brisgand, D. AU - Douillard, J. Y. PY - 1994 DA - 1994// TI - Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients JO - J Clin Oncol VL - 12 UR - https://doi.org/10.1200/JCO.1994.12.2.360 DO - 10.1200/JCO.1994.12.2.360 ID - Chevalier1994 ER - TY - JOUR AU - Wozniak, A. J. AU - Crowley, J. J. AU - Balcerzak, S. P. PY - 1998 DA - 1998// TI - Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study JO - J Clin Oncol VL - 16 UR - https://doi.org/10.1200/JCO.1998.16.7.2459 DO - 10.1200/JCO.1998.16.7.2459 ID - Wozniak1998 ER - TY - JOUR AU - Chevalier, T. AU - Scagliotti, G. AU - Natale, R. PY - 2005 DA - 2005// TI - Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes JO - Lung Cancer VL - 47 UR - https://doi.org/10.1016/j.lungcan.2004.10.014 DO - 10.1016/j.lungcan.2004.10.014 ID - Chevalier2005 ER - TY - JOUR AU - Douillard, J. Y. AU - Laporte, S. AU - Fossella, F. PY - 2007 DA - 2007// TI - Comparison of docetaxel- and vinca alkaloid-based chemotherapy in the first-line treatment of advanced non-small cell lung cancer: a meta-analysis of seven randomized clinical trials JO - J Thorac Oncol VL - 2 UR - https://doi.org/10.1097/JTO.0b013e318153fa2b DO - 10.1097/JTO.0b013e318153fa2b ID - Douillard2007 ER - TY - JOUR AU - Grossi, F. AU - Aita, M. AU - Defferrari, C. PY - 2009 DA - 2009// TI - Impact of third-generation drugs on the activity of first-line chemotherapy in advanced non-small cell lung cancer: a meta-analytical approach JO - Oncologist VL - 14 UR - https://doi.org/10.1634/theoncologist.2008-0260 DO - 10.1634/theoncologist.2008-0260 ID - Grossi2009 ER - TY - JOUR AU - Quoix, E. AU - Zalcman, G. AU - Oster, J. P. PY - 2011 DA - 2011// TI - Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial JO - Lancet VL - 378 UR - https://doi.org/10.1016/S0140-6736(11)60780-0 DO - 10.1016/S0140-6736(11)60780-0 ID - Quoix2011 ER - TY - JOUR AU - Fossella, F. V. AU - DeVore, R. AU - Kerr, R. N. PY - 2000 DA - 2000// TI - Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy regimens. The TAX 320 Non-Small Cell Lung Cancer Study Group JO - J Clin Oncol VL - 18 UR - https://doi.org/10.1200/JCO.2000.18.12.2354 DO - 10.1200/JCO.2000.18.12.2354 ID - Fossella2000 ER - TY - JOUR AU - Devlin, J. G. AU - Langer, C. J. PY - 2007 DA - 2007// TI - Salvage therapy with vinorelbine in advanced non-small-cell lung cancer: a retrospective review of the Fox Chase Cancer Center experience and a review of the literature JO - Clin Lung Cancer VL - 8 UR - https://doi.org/10.3816/CLC.2007.n.011 DO - 10.3816/CLC.2007.n.011 ID - Devlin2007 ER - TY - JOUR AU - Briasoulis, E. AU - Pappas, P. AU - Puozzo, C. AU - Tolis, C. AU - Fountzilas, G. AU - Dafni, U. AU - Marselos, M. AU - Pavlidis, N. PY - 2009 DA - 2009// TI - Dose-ranging study of metronomic oral vinorelbine in patients with advanced refractory cancer JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-09-0970 DO - 10.1158/1078-0432.CCR-09-0970 ID - Briasoulis2009 ER - TY - JOUR AU - Briasoulis, E. AU - Aravantinos, G. AU - Kouvatseas, G. AU - Pappas, P. AU - Biziota, E. AU - Sainis, I. PY - 2013 DA - 2013// TI - Dose selection trial of metronomic oral vinorelbine monotherapy in patients with metastatic cancer: a hellenic cooperative oncology group clinical translational study JO - BMC Cancer VL - 13 UR - https://doi.org/10.1186/1471-2407-13-263 DO - 10.1186/1471-2407-13-263 ID - Briasoulis2013 ER - TY - JOUR AU - Kontopodis, E. AU - Hatzidaki, D. AU - Varthalitis, I. AU - Kentepozidis, N. AU - Giassas, S. AU - Pantazopoulos, N. AU - Vardakis, N. AU - Rovithi, M. AU - Georgoulias, V. AU - Agelaki, S. PY - 2013 DA - 2013// TI - A phase II study of metronomic oral vinorelbine administered in the second line and beyond in non-small cell lung cancer (NSCLC): a phase II study of the Hellenic Oncology Research Group JO - J Chemother VL - 25 UR - https://doi.org/10.1179/1973947812Y.0000000050 DO - 10.1179/1973947812Y.0000000050 ID - Kontopodis2013 ER - TY - JOUR AU - Camerini, A. AU - Puccetti, C. AU - Donati, S. AU - Valsuani, C. AU - Petrella, M. C. AU - Tartarelli, G. AU - Puccinelli, P. AU - Amoroso, D. PY - 2015 DA - 2015// TI - Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial) JO - BMC Cancer VL - 15 UR - https://doi.org/10.1186/s12885-015-1354-2 DO - 10.1186/s12885-015-1354-2 ID - Camerini2015 ER - TY - JOUR AU - Zandwijk, N. AU - Clarke, C. AU - Henderson, D. AU - Musk, A. W. AU - Fong, K. AU - Nowak, A. AU - Loneragan, R. AU - McCaughan, B. AU - Boyer, M. AU - Feigen, M. AU - Currow, D. AU - Schofield, P. AU - Nick Pavlakis, B. I. AU - McLean, J. AU - Marshall, H. AU - Leong, S. AU - Keena, V. AU - Penman, A. PY - 2013 DA - 2013// TI - Guidelines for the diagnosis and treatment of malignant pleural mesothelioma JO - J Thorac Dis VL - 5 ID - Zandwijk2013 ER - TY - JOUR AU - Stebbing, J. AU - Powles, T. AU - McPherson, K. AU - Shamash, J. AU - Wells, P. AU - Sheaff, M. T. AU - Slater, S. AU - Rudd, R. M. AU - Fennell, D. AU - Steele, J. P. PY - 2009 DA - 2009// TI - The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma JO - Lung Cancer VL - 63 UR - https://doi.org/10.1016/j.lungcan.2008.04.001 DO - 10.1016/j.lungcan.2008.04.001 ID - Stebbing2009 ER - TY - JOUR AU - Zucali, P. A. AU - Perrino, M. AU - Lorenzi, E. AU - Ceresoli, G. L. AU - Vincenzo, F. AU - Simonelli, M. AU - Gianoncelli, L. AU - Sanctis, R. AU - Giordano, L. AU - Santoro, A. PY - 2014 DA - 2014// TI - Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma JO - Lung Cancer VL - 84 UR - https://doi.org/10.1016/j.lungcan.2013.11.011 DO - 10.1016/j.lungcan.2013.11.011 ID - Zucali2014 ER - TY - JOUR AU - Faivre, C. AU - Barbolosi, D. AU - Pasquier, E. AU - André, N. PY - 2013 DA - 2013// TI - A mathematical model for the administration of temozolomide: comparative analysis of conventional and metronomic chemotherapy regimens JO - Cancer Chemother Pharmacol VL - 71 UR - https://doi.org/10.1007/s00280-013-2095-z DO - 10.1007/s00280-013-2095-z ID - Faivre2013 ER - TY - JOUR AU - Hahnfeldt, P. AU - Folkman, J. AU - Hlatky, L. PY - 2003 DA - 2003// TI - Minimizing long-term tumor burden: the logic for metronomic chemotherapeutic dosing and its antiangiogenic basis JO - J Theor Biol VL - 220 UR - https://doi.org/10.1006/jtbi.2003.3162 DO - 10.1006/jtbi.2003.3162 ID - Hahnfeldt2003 ER - TY - JOUR AU - Meille, C. AU - Iliadis, A. AU - Barbolosi, D. AU - Frances, N. AU - Freyer, G. PY - 2008 DA - 2008// TI - An interface model for dosage adjustment connects hematotoxicity to pharmacokinetics JO - J Pharmacokinet Pharmacodyn VL - 35 UR - https://doi.org/10.1007/s10928-008-9106-4 DO - 10.1007/s10928-008-9106-4 ID - Meille2008 ER - TY - JOUR AU - Meille, C. AU - Gentet, J. C. AU - Barbolosi, D. AU - André, N. AU - Doz, F. AU - Iliadis, A. PY - 2008 DA - 2008// TI - New adaptive method for phase I trials in oncology JO - Clin Pharmacol Ther VL - 83 UR - https://doi.org/10.1038/sj.clpt.6100383 DO - 10.1038/sj.clpt.6100383 ID - Meille2008 ER - TY - JOUR AU - Marouani, H. AU - Woloch, C. AU - Benay, S. AU - Frances, N. AU - Iliadis, A. PY - 2012 DA - 2012// TI - Progress in strategies for dosage regimen individualization JO - Curr Top Med Chem VL - 12 UR - https://doi.org/10.2174/156802612803531315 DO - 10.2174/156802612803531315 ID - Marouani2012 ER - TY - JOUR AU - Barbolosi, D. AU - Ciccolini, J. AU - Meille, C. AU - Elharrar, X. AU - Faivre, C. AU - Lacarelle, B. AU - André, N. AU - Barlesi, F. PY - 2014 DA - 2014// TI - Metronomics chemotherapy: time for computational decision support JO - Cancer Chemother Pharmacol VL - 74 UR - https://doi.org/10.1007/s00280-014-2546-1 DO - 10.1007/s00280-014-2546-1 ID - Barbolosi2014 ER - TY - JOUR AU - Variol, P. AU - Nguyen, L. AU - Tranchand, B. AU - Puozzo, C. PY - 2002 DA - 2002// TI - A simultaneous oral/intravenous population pharmacokinetic model for vinorelbine JO - Eur J Clin Pharmacol VL - 58 UR - https://doi.org/10.1007/s00228-002-0506-x DO - 10.1007/s00228-002-0506-x ID - Variol2002 ER - TY - STD TI - Keyvan Rezai Gharahbolagh. Variabilité pharmacocinétique des anti-cancéreux : Application a la vinorelbine et au lapatinib. Human health and pathology. Université René Descartes - Paris V, 2012. French. http://www.theses.fr/2012PA05P606. Accessed 11 May 2015. UR - http://www.theses.fr/2012PA05P606 ID - ref36 ER - TY - JOUR AU - Friberg, L. E. AU - Henningsson, A. AU - Maas, H. AU - Nguyen, L. AU - Karlsson, M. O. PY - 2002 DA - 2002// TI - Model of chemotherapy-induced myelosuppression with parameter consistency across drugs JO - J Clin Oncol VL - 20 UR - https://doi.org/10.1200/JCO.2002.02.140 DO - 10.1200/JCO.2002.02.140 ID - Friberg2002 ER - TY - JOUR AU - Nguyen, L. AU - Tranchand, B. AU - Puozzo, C. AU - Variol, P. PY - 2002 DA - 2002// TI - Population pharmacokinetics model and limited sampling strategy for intravenous vinorelbine derived from Phase I clinical trials JO - Br J Clin Pharmacol VL - 53 UR - https://doi.org/10.1046/j.1365-2125.2002.01581.x DO - 10.1046/j.1365-2125.2002.01581.x ID - Nguyen2002 ER - TY - JOUR AU - Agur, Z. AU - Elishmereni, M. AU - Kheifetz, Y. PY - 2014 DA - 2014// TI - Personalizing oncology treatments by predicting drug efficacy, side-effects, and improved therapy: mathematics, statistics, and their integration JO - Wiley Interdiscip Rev Syst Biol Med VL - 6 UR - https://doi.org/10.1002/wsbm.1263 DO - 10.1002/wsbm.1263 ID - Agur2014 ER - TY - JOUR AU - Lee, J. J. AU - Chu, C. T. PY - 2012 DA - 2012// TI - Bayesian clinical trials in action JO - Stat Med VL - 31 UR - https://doi.org/10.1002/sim.5404 DO - 10.1002/sim.5404 ID - Lee2012 ER -